In MD+DI, RQM+ makes the case that compliance consulting has become an operating-model decision rather than a staffing fix. The article lays out four variables for what a lean team should own versus route to specialized partners, including safety sciences like biocompatibility and E&L.
What You’ll Learn
- Why post-MDR insourcing left quality and regulatory teams stretched
- Why comparing a consultant’s bill rate to a full-time hire misses most of the real cost
- The four variables that determine what to keep internal and what to route to specialized partners
